Navigation Links
Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
Date:5/11/2009

CAMBRIDGE, Mass., May 11 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the upcoming Deutsche Bank 2009 Health Care Conference on Monday, May 18, 2009 at 8:40 a.m. ET at the Intercontinental Hotel, Boston.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus. For further information about Idenix, please refer to http://www.idenix.com.

    Idenix Pharmaceuticals Contact:
    Teri Dahlman 617-995-9905


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals Reports First Quarter Financial Results
2. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
3. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
4. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
5. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
6. Idenix to Host Conference Call Discussing Fourth Quarter 2008 Financial Results
7. Idenix Pharmaceuticals to Present at the JP Morgan 27th Annual Healthcare Conference
8. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
10. Idenix to Host Conference Call Discussing Third Quarter 2008 Financial Results
11. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... PUNE, India , December 8, 2016 ... is a comprehensive analysis, titled Global Amyloglucosidase Industry 2016 Market ... definition, classification, application, and industry chain overview are all covered ... project SWOT analysis, and investment return analysis of the Amyloglucosidase ... , , ...
(Date:12/8/2016)... USA, and CARDIFF, UK (PRWEB) , ... December ... ... with very high precision light to control cells — optogenetics — is key ... the current state of the art, spatially patterned light projected via free-space optics ...
(Date:12/8/2016)...  Anaconda BioMed S.L., a pre-clinical stage medical device ... neuro-thrombectomy system for the treatment of Acute Ischemic Stroke ... to join its Scientific Advisory Board (SAB). The SAB ... scientific and clinical experts to Anaconda BioMed S.L., as ... ® to its clinical phase. The SAB is ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review and report looks ... authors focus on the economic effects in countries that are major global commodity exporters ... and the resultant risk of low level presence (LLP) puts large volumes of trade ...
Breaking Biology Technology:
(Date:11/28/2016)... "The biometric system market ... The biometric system market is in the growth stage ... future. The biometric system market is expected to be ... CAGR of 16.79% between 2016 and 2022. Government initiative ... in smartphones, rising use of biometric technology in financial ...
(Date:11/19/2016)... 2016 Securus Technologies, a leading provider of ... investigation, corrections and monitoring, announced today that it has ... have an independent technology judge determine who has the ... tech/sophisticated telephone calling platform, and the best customer service. ... most of what we do – which clearly is ...
(Date:11/15/2016)... 15, 2016 Research and Markets has announced ... 2021" report to their offering. ... ... by 2021 from USD 6.21 Billion in 2016, growing at a ... of the bioinformatics market is driven by the growing demand for ...
Breaking Biology News(10 mins):